Short Summary
Tekelec, Inc. filed a miscellaneous petition seeking reinstatement of claim No. 32 in Patent Application No. 7133/CHENP/2009. The court noted that the petitioner's counsel was not pressing the petition and closed the matter at the SR stage.
Detailed Summary
of the Paris Local Division of the Unified Patent Court concerning a request for extension of time filed by the Bosch defendants. The judge-rapporteur rejected Bosch's request, finding that a non-redacted version of Valeo's 15 June 2026 filing had been deposited in the CMS simultaneously with the redacted version, and that Bosch had failed to exercise due diligence in accessing it. The court ruled that the deadlines under R.29(d) RdP run from 15 June 2026.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Madras High Court. Understanding the court's reasoning in Tekelec, Inc. vs The Controller of Patents is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
S.S. Products Of IndiavsStar Plast
S.S. Products Of India filed a suit for permanent injunction against Star Plast, alleging infringement of their registered air pump design (No. 176150). The defendant contested the suit by pointing out that they also held a valid registration (No. 182208) and challenging the court's jurisdiction.
Troikaa Pharmaceuticals LtdvsAkums Drugs and Pharmaceuticals Ltd & 2
The suit concerned the dispute between Troikaa Pharmaceuticals Ltd and Akums Drugs regarding the manufacture of Diclofenac Sodicum Injection. The High Court modified an earlier ex-parte interim relief, based on a consensus reached by both parties in a previous appeal, extending the injunction until June 19, 2012.
Research Foundation, Sci., Tech. & Eco. & Anr.vsUnion of India & Ors.
The petitioners filed a writ petition seeking directions to the Union of India to challenge patents related to wheat in international forums, citing concerns over biodiversity protection and biopiracy. The court noted that the specific patent challenged had since been revoked by the European Patent Office.
Bristol-Myers Squibb Company & OrsvsDr.Bps Reddy & Ors
The plaintiffs filed a suit for permanent injunction against defendants regarding infringement of Patent No. 203937 concerning DASATINIB API. The court addressed three applications: one to implead Hetero Labs Ltd., one to delete Dr. BPS Reddy, and one to implead Bristol-Myers Squibb Holdings Ireland as the assignee. All three applications were allowed.
Bayer CorporationvsUnion Of India & Ors
Bayer challenged Natco's (and Alembic's) exports of SORAFENIB/SORAFENAT, which were covered by a Compulsory Licence, arguing these exports infringed the patent. The core legal question was whether Section 107A allowed for such exports for regulatory purposes.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.